艾滋病毒感染者的脆弱状态中的镇静药联合治疗模式:基于网络的研究
Henry Ukachukwu Michael1,2, Marie-Josée Brouillette3,4,5, Robyn Tamblyn6,7
1Division of Clinical and Translational Research, McGill University, Montreal, QC, Canada. henry.michael@mail.mcgill.ca.
International journal of clinical pharmacy
|July 15, 2025
概括
艾滋病毒感染者的脆弱性增加了镇静剂联合治疗的复杂性和高风险的药物相互作用. 药物安全前期为改善药物安全的干预提供了关键机会.
科学领域:
- 老年学是指老年学的学科.
- 药理学 药理学是指药理学的学科.
- 传染病 (艾滋病毒/艾滋病)
背景情况:
- 艾滋病毒感染者的寿命越来越长,增加了虚弱和不良药物相互作用的风险.
- 镇静药物在患有艾滋病毒的脆弱个体中具有药物相互作用的特殊风险.
研究的目的:
- 分析艾滋病毒感染者的不同脆弱状态 (强壮,弱弱前,弱弱) 中的镇静剂联合治疗模式.
- 识别导致复杂药物相互作用的特定药物.
- 了解脆弱如何影响镇静剂多药和相互作用风险.
主要方法:
- 对321名使用镇静剂的参与者进行了横截面分析,这些参与者来自积极的大脑健康现在队列.
- 根据修改后的脆性现象型,将参与者分为强壮,脆弱前和脆弱的群体.
- 使用镇静剂负载模型,邻里转移得分 (NESH) 和 ΔBetweenness 的镇静剂联合药物的基于网络的分析.
主要成果:
- 脆弱个体表现出最复杂的镇静网络 (图密度:0.24),其次是脆弱前 (0.18) 和强壮 (0.13) 组.
- 影响网络复杂性的关键药物包括米尔塔扎, gabapentin 和pregabalin.
- 高风险的镇静剂对在脆弱的个体中更为普遍 (例如,摩-克洛纳西巴姆),在脆弱前的个体中风险中等.
结论:
- 镇静剂联合治疗模式和相互作用风险随着艾滋病毒感染者的脆弱性逐渐增加而显著增加.
- 临床前期是干预措施的关键窗口,以减少多药和提高药物安全.
- 识别关键药物和网络模式可以为这一群体指导更安全的处方实践.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
245
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
245
Sedatives and Hypnotics: Overview
662
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
662
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Depressants
181
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
181
Sedatives and Hypnotics Drugs: Barbiturates
497
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
497
Sedatives and Hypnotics Drugs: Benzodiazepines
394
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
394


